Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff
  • Print
  • Share
  • E-mail
-

Search Publications



Fields



Centers











Starting Date


Ending Date


Order by

Entry Details

Clin Pharmacol Ther 2012 Sep;92(3):267-71

Gastrohepatology: tools, targets, and trajectories.

James LP, Senior J

Abstract

Gastrointestinal (GI) and hepatic conditions are a leading source of health-care utilization today. A significant segment of the over-the-counter and prescription drug market comprises drugs used to alleviate symptoms localized to the alimentary tract. The discovery of new mechanisms of disease pathogenesis will inform the future development of targeted therapeutics for conditions managed by gastroenterologists and hepatologists. Newly approved drugs and evolving mechanistic targets offer a promising trajectory to both clinicians and patients with GI and liver disorders.

Category: Journal Article, Editorial
PubMed ID: #22910480 DOI: 10.1038/clpt.2012.123
Includes FDA Authors from Scientific Area(s): Drugs
Entry Created: 2012-10-01
Feedback
-
-